Acquiring determined the palmitoylation motif of APLNR, we developed a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation web-site together with morphine, can inhibit the development of NCP, which include pain incidence, microglial activation, and inflammatory component launch https://victore775tel4.theblogfairy.com/26512512/block-pain-receptors-with-proleviate-for-dummies